Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-07-25 Option Award | 2025-07-30 9:30 pm | N/A N/A | ImageneBio Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 83,611 | $2.49 | 773,754 (Indirect) | View |
2024-09-16 Conversion | 2024-09-17 8:13 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 39,876,501 | $0 | 653,787 (Indirect) | View |
Ownership | 2024-09-12 7:14 pm | N/A N/A | MBX Biosciences Inc. | MBX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 0 | $0 | 3,062,215 (Indirect) | View |
2024-05-18 Equity Swap | 2024-05-20 7:47 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 2,680,496 | $0 | 0 (Indirect) | View |
2024-02-14 Equity Swap | 2024-02-14 4:02 pm | N/A N/A | Theseus Pharmaceuticals Inc. | THRX | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 17,713,600 | $0 | 0 (Indirect) | View |
2024-01-11 Exercise | 2024-01-16 4:39 pm | N/A N/A | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 145,251 | $12.74 | 2,680,496 (Indirect) | View |
2024-01-11 Exercise | 2024-01-16 4:39 pm | 2019-01-18 2024-01-18 | ALPINE IMMUNE SCIENCES INC. | ALPN | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 145,251 | $0 | 2,680,496 (Indirect) | View |
2023-12-18 Exercise | 2023-12-20 6:28 pm | N/A N/A | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 1,724 | $38 | 1,702,237 (Direct) | View |
2023-12-18 Exercise | 2023-12-20 6:28 pm | N/A 2031-10-03 | Disc Medicine Inc. | IRON | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Capital GP VIII LLC OrbiMed Genesis GP LLC Director | 1,724 | $0 | 1,702,237 (Direct) | View |
2023-08-04 Option Award(A) | 2023-09-21 5:02 pm | N/A N/A | Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 506,313 | $0 | 8,281,735 (Indirect) | View |
2023-08-04 Option Award | 2023-09-14 9:22 pm | N/A N/A | Ikena Oncology Inc. | IKNA | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Genesis GP LLC Director | 506,313 | $0 | 8,281,735 (Indirect) | View |
2023-05-17 Exercise | 2023-05-19 4:19 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 2,125 | $4.28 | 8,951,463 (Indirect) | View |
2023-05-17 Exercise | 2023-05-19 4:19 pm | N/A 2032-06-01 | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 2,125 | $0 | 8,951,463 (Indirect) | View |
2023-02-23 Option Award | 2023-02-27 8:30 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Genesis GP LLC Director 10% Owner | 7,899,572 | $0 | 288,114 (Indirect) | View |